IBN SINA Pharmaceutical Industry

IBN SINA Pharmaceutical Industry

Photo: Collected

Ibn Sina posts 33% EPS growth in 9-month despite Q3 dip

Meanwhile, the company’s consolidated net asset value (NAV) increased to Tk434.61 crore, up from Tk392.69 crore in the previous period

Photo: Collected

HC issues rule over Ibn Sina's 'muslim men only' recruitment notice

Photo: Collected

IBN SINA declares 64% cash dividend for FY25

IBN Sina Pharma's profit grows 13% in H1

IBN Sina Pharma's profit grows 13% in H1

IBN SINA recommends 60% cash dividend for FY23

IBN SINA recommends 60% cash dividend for FY23

IBN Sina Pharma changes name to The IBN SINA Pharmaceutical Industry PLC

IBN Sina Pharma changes name to The IBN SINA Pharmaceutical Industry PLC

IBN SINA holds 38th AGM

IBN SINA holds 38th AGM

IBN Sina’s profit grows 40% in Q1

IBN Sina’s profit grows 40% in Q1

IBN SINA Pharma recommends highest cash dividends in 12 years

IBN SINA Pharma recommends highest cash dividends in 12 years